CCL5 and neoplasm: For example, the use of CDK4/6 inhibitors in melanoma cells can induce the secretion of tumor cells through CCL5, which relies on the NF-κB signal and promotes the recruitment of tumor-infiltrating leukocytes [97], which is the result of stimulating antitumor immunity.